Download Mobile App

Video Library

Partner Sites

HospiMedica

AI-Guided Screening Uses ECG Data to Detect Hidden Risk Factor for Stroke

Vein Visualization Device Allows Clinicians to Accurately View Center-Line Regardless of Distance

One-Time Blood Test Predicts Which Hospitalized COVID-19 Patients Will Grow Worse

Fecal Transplantation an Effective Remedy for Life-Threatening Intestinal Infections

World's First Minimally Invasive Brain Pacemaker Treats Epilepsy

GC Labs Highlight Its “Smart Lab” Concept at MEDLAB Middle East 2022

By LabMedica International staff writers
Posted on 24 Jan 2022

Image: GC Labs Highlight Its `Smart Lab` Concept at MEDLAB Middle East 2022 (Photo courtesy of GC Labs)

GC Labs (Yongin, South Korea) participated in the 2022 edition of MEDLAB Middle East held at the Dubai World Trade Centre (DWTC) from January 24 to 27 where it offered a ‘smart experience’ for visitors to learn more about the diagnostic services offered by the company.

At the event, GC Labs highlighted its “smart lab” concept that provides an automated test system to improve speed and efficiency of tests, allowing the company to report results in just a day or two. The increase in demand for genetics and infectious disease tests in the region has prompted GC Labs to plan further expansion in the Middle East. Currently offering their services in Saudi Arabia and the UAE, the company is in talks with regional partners to expand their services to more countries in the Middle East. More than 800 employees at GC Labs offer over 5,000 tests and test combinations, ranging from routine tests to highly esoteric molecular and genetic assays.

GC Labs hosted its seminar on ‘Public-Private Partnership in Global Health: bringing the best of both worlds to improve testing’ on January 25 at the Bubble Lounge in Medlab. The seminar had an impressive line-up of speakers with globally renowned specialists including Lelio Marmora, former CEO in Unitaid; Michel Kazatchkine, former executive director the Global Fund to Fight AIDS, TB and Malaria; Dr Eskild Petersen, MD, Editor-in-chief of IJID Regions, an official journal of the International Society for Infectious Diseases (ISID); Dr Amina Al-Jardani, Director of Central Public Health Laboratories (CPHL), Directorate General for Disease Surveillance and Control, Ministry of Health, Oman; and Lee. The seminar was an interactive session with an opportunity for attendees to ask questions.

“The Middle East is an important market for us, and participating in MEDLAB will help us to share our best practices in clinical diagnostics with the regional health community. Over the past two decades, the world has achieved important success in the fight against pandemics like COVID-19 and in mobilizing global response against HIV-Aids, TB, Malaria and other infectious diseases,” said Eun-Hee Lee, President at GC Labs. “Medical laboratories play a key role in this fight by providing high quality diagnostic testing and by working in partnership with the health authorities. To highlight the importance of private and public partnership in the fight against infectious diseases and pandemics, we are organizing a seminar during MEDLAB to bring together international experts to share their own experiences and expertise, focus on lessons learned, and discuss how to best manage public and private partnerships to successfully fight against pandemics and infectious diseases in the future.”

Related Links:
GC Labs